Pelthos Therapeutics CFO Sells Stake While Company Faces Earnings Miss
The Chief Financial Officer of Pelthos Therapeutics Inc., Francis Knuettel II, reported selling a portion of his common stock. Concurrently, the company released its Q1 2026 earnings report, which revealed a significant shortfall in earnings per share (EPS). Despite this financial setback, PTHS saw an increase in its stock price, suggesting varied …